1 / 8

Platinum Based Cancer Drugs market size is expected to reach USD 1814.1 Million by 2026

The global Platinum Based Cancer Drugs market size is expected to reach USD 1814.1 Million by 2026 according to a new study by Polaris Market Research.

karishmamtip
Download Presentation

Platinum Based Cancer Drugs market size is expected to reach USD 1814.1 Million by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Platinum Based Cancer Drugs Market Set to Exceed $1,814.1 Mn By 2026 | CAGR 4.1%

  2. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 “Global Platinum Based Cancer Drugs Market Share, Size, Trends, Industry Analysis Report By Drug Type (Cisplatin, Oxaliplatin, Carboplatin, Other), By Application (Colorectal Cancer, Ovarian Cancer, Lung Cancer, Other); By Regions, and Segment Forecast, 2019 - 2026” The global platinum based Cancer drugs market size is expected to reach USD 1,814.1 Million by 2026 according to a new study by Polaris Market Research. Drugs based on platinum have become a major component of cancer therapy; about half of all patients undergoing chemotherapy receive a platinum drug. The widespread use of platinum agents in cancer treatment started with Barnett Rosenberg’s discovery of cisplatin’s antineoplastic activity in the 1960s. According to the National Cancer Institute, the instances of new cases per year is expected to rise to 23.6 million by 2030. Nevertheless, the major limitations of this industry worldwide are the drug- related side effects and resistance growth. Recent developments in platinum based cancer drugs include the development of analog platinum drugs such as platinum carrier molecule complexes to boost targeted concentration of drugs in cancer tumor. This increasing number of cancer instances is expected to drive the growth of the global platinum cancer drug market during the forecast period. Browse Detailed Research Report On Platinum Based Cancer Drugs Market Analysis: https://www.polarismarketresearch.com/industry-analysis/platinum-based-cancer-drugs- market The platinum based cancer drugs market can be categorized in terms of product type as oxaliplatin, cisplatin, carboplatin, and others. Cisplatin is the most commonly used for treating certain malignancies. It is particularly effective in testicular cancer and is intravenously administered. Carboplatin, a derivative of cisplatin, is used to treat multiple cancers like ovaries, lungs, brains, and so on. Cisplatin’s segment maintained the largest market share in 2018 and is expected to remain dominant over the forecast period. Based on application, the global market is divided into ovarian, lung, testicular, colorectal, and other cancer. The lung cancer segment dominated the market in 2018 due to the high incidence among the world’s population. Request for sample: https://www.polarismarketresearch.com/industry-analysis/platinum- based-cancer-drugs-market/request-for-sample Due to enhanced disease prevalence, enhanced awareness, increased per capita income, and enhanced health care infrastructure, the Asia Pacific market is anticipated to develop at the largest CAGR. North America dominated the global market in 2018 due to the high incidence of cancer in the region, developments in these drugs and recent FDA approvals. United States is the world’s largest - 2 -

  3. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 drug market. This has led to the dominance of North America in the global platinum cancer drug market. The U.S. pharmaceutical industry is the largest domestic market in the world. It is the world’s biggest continental pharmaceutical market together with Canada and Mexico. More than 45 percent of the worldwide pharmaceutical industry is held by the United States alone. This share was valued at approximately $446 Million in 2016. Many of the top worldwide firms are from the U.S. In 2016, six out of the top 10 firms were based on sheer pharmaceutical income from the United States. Major players in the platinum cancer drug market include Sanofi, Pfizer, Inc., Mylan N.V., Ask- Pharma, Sun Pharmaceutical Industries Ltd., Accord Healthcare, Novartis AG, Teva Pharmaceutical Industries Ltd., Guizhou YiBai Pharmaceutical Co., Ltd., SK Chemicals, Qilu Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., Debiopharm Group, and Jiangsu Hengrui Pharmaceutical Co., Ltd. TABLE OF CONTENTS 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources 1.3.2. Secondary data sources 1.4. Key take-aways 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Platinum Based Cancer Drugs Market Insights 3.1. Platinum Based Cancer Drugs – Industry snapshot 3.2. Platinum Based Cancer Drugs market dynamics 3.2.1. Platinum Based Cancer Drugs – Market Forces 3.2.1.1. Platinum Based Cancer Drugs Market driver analysis 3.2.1.2. Platinum Based Cancer Drugs Market restraint/challenges analysis 3.2.1.3. Platinum Based Cancer Drugs Market opportunity analysis 3.3. Industry analysis - Porter's five force 3.3.1. Bargaining power of supplier 3.3.2. Bargaining power of buyer 3.3.3. Threat of substitute 3.3.4. Threat of new entrant 3.3.5. Degree of competition 3.4. Platinum Based Cancer Drugs market PEST analysis 3.5. Value Chain Analysis 3.6. Competitive Ranking Analysis, 2018 4. Platinum Based Cancer Drugs Market Size and Forecast by Drug Type 4.1. Global Platinum Based Cancer Drugs market share by Drug Type, 2018 & 2026 4.2. Cisplatin - 3 -

  4. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 4.2.1. Global cisplatin Platinum Based Cancer Drugs market estimates and forecasts, 2015 - 2026 (USD Million) 4.2.2. Global cisplatin Platinum Based Cancer Drugs market estimates and forecasts, by region, 2015 - 2026 (USD Million) 4.3. Oxaliplatin 4.3.1. Global oxaliplatin Platinum Based Cancer Drugs market estimates and forecasts, 2015 - 2026 (USD Million) 4.3.2. Global oxaliplatin Platinum Based Cancer Drugs market estimates and forecasts, by region, 2015 - 2026 (USD Million) 4.4. Carboplatin 4.4.1. Global carboplatin Platinum Based Cancer Drugs market estimates and forecasts, 2015 - 2026 (USD Million) 4.4.2. Global carboplatin Platinum Based Cancer Drugs market estimates and forecasts, by region, 2015 - 2026 (USD Million) 4.5. Others 4.5.1. Global other Platinum Based Cancer Drugs market estimates and forecasts, 2015 - 2026 (USD Million) 4.5.2. Global other Platinum Based Cancer Drugs market estimates and forecasts, by region, 2015 - 2026 (USD Million) 5. Platinum Based Cancer Drugs Market Size and Forecast by Application 5.1. Global Platinum Based Cancer Drugs market share by application, 2018 & 2026 5.2. Colorectal Cancer 5.2.1. Global Platinum Based Cancer Drugs market estimates and forecasts for colorectal cancer, 2015 - 2026 (USD Million) 5.2.2. Global Platinum Based Cancer Drugs market estimates and forecasts for colorectal cancer, by region, 2015 - 2026 (USD Million) 5.3. Ovarian Cancer 5.3.1. Global Platinum Based Cancer Drugs market estimates and forecasts for ovarian cancer, 2015 - 2026 (USD Million) 5.3.2. Global Platinum Based Cancer Drugs market estimates and forecasts for ovarian cancer, by region, 2015 - 2026 (USD Million) 5.4. Lung Cancer 5.4.1. Global Platinum Based Cancer Drugs market estimates and forecasts for lung cancer, 2015 - 2026 (USD Million) 5.4.2. Global Platinum Based Cancer Drugs market estimates and forecasts for lung cancer, by region, 2015 - 2026 (USD Million) 5.5. Others 5.5.1. Global Platinum Based Cancer Drugs market estimates and forecasts for others, 2015 - 2026 (USD Million) 5.5.2. Global Platinum Based Cancer Drugs market estimates and forecasts for others, by region, 2015 - 2026 (USD Million) 6. Platinum Based Cancer Drugs Market Size and Forecast by Region 6.1. Global Platinum Based Cancer Drugs market share by region, 2018 & 2026 6.2. North America 6.2.1. North America Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.2.2. North America Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.2.3. U.S. 6.2.3.1. U.S. Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 - 4 -

  5. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 U.S. Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.2.4. Canada 6.2.4.1. Canada Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.2.4.2. Canada Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.3. Europe 6.3.1. Europe Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.3.2. Europe Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.3.3. Germany 6.3.3.1. Germany Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.3.3.2. Germany Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.3.4. UK 6.3.4.1. UK Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.3.4.2. UK Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.3.5. France 6.3.5.1. France Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.3.5.2. France Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.3.6. Italy 6.3.6.1. Italy Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.3.6.2. Italy Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.3.7. Russia 6.3.7.1. Russia Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.3.7.2. Russia Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.4. Asia Pacific 6.4.1. Asia Pacific Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.4.2. Asia Pacific Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.4.3. China 6.4.3.1. China Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.4.3.2. China Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.4.4. South Korea 6.4.4.1. South Korea Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.4.4.2. South Korea Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.2.3.2. - 5 -

  6. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 6.4.5. Japan 6.4.5.1. Japan Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.4.5.2. Japan Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.4.6. India 6.4.6.1. India Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.4.6.2. India Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.5. Latin America 6.5.1. Latin America Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.5.2. Latin America Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.5.3. Brazil 6.5.3.1. Brazil Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.5.3.2. Brazil Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.5.4. Mexico 6.5.4.1. Mexico Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.5.4.2. Mexico Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.5.5. Colombia 6.5.5.1. Colombia Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.5.5.2. Colombia Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.6. Middle East & Africa 6.6.1. MEA Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.6.2. MEA Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.6.3. Saudi Arabia 6.6.3.1. Saudi Arabia Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.6.3.2. Saudi Arabia Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.6.4. South Africa 6.6.4.1. South Africa Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.6.4.2. South Africa Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.6.5. Israel 6.6.5.1. Israel Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.6.5.2. Israel Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 6.6.6. UAE - 6 -

  7. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 UAE Platinum Based Cancer Drugs market by Drug Type (USD Million), 2015 - 2026 6.6.6.2. UAE Platinum Based Cancer Drugs market by application type (USD Million), 2015 - 2026 7. Company Profiles 7.1. Sanofi 7.1.1. Overview 7.1.2. Financials 7.1.3. Product Benchmarking 7.1.4. Recent Developments 7.2. Pfizer, Inc. 7.2.1. Overview 7.2.2. Financials 7.2.3. Product Benchmarking 7.2.4. Recent Developments 7.3. Mylan N.V 7.3.1. Overview 7.3.2. Financials 7.3.3. Product Benchmarking 7.3.4. Recent Developments 7.4. Ask-Pharma 7.4.1. Overview 7.4.2. Financials 7.4.3. Product Benchmarking 7.4.4. Recent Developments 7.5. Sun Pharmaceutical Industries Ltd 7.5.1. Overview 7.5.2. Financials 7.5.3. Product Benchmarking 7.5.4. Recent Developments 7.6. Accord Healthcare 7.6.1. Overview 7.6.2. Financials 7.6.3. Product Benchmarking 7.6.4. Recent Developments 7.7. Novartis AG 7.7.1. Overview 7.7.2. Financials 7.7.3. Product Benchmarking 7.7.4. Recent Developments 7.8. Teva Pharmaceutical Industries Ltd 7.8.1. Overview 7.8.2. Financials 7.8.3. Product Benchmarking 7.8.4. Recent Developments 7.9. Guizhou YiBai Pharmaceutical Co., Ltd 7.9.1. Overview 7.9.2. Financials 7.9.3. Product Benchmarking 7.9.4. Recent Developments 7.10. SK Chemicals 7.10.1. Overview 6.6.6.1. - 7 -

  8. Platinum Based Cancer Drugs Market Size Worth $1,814.1 Mn By 2026 7.10.2. Financials 7.10.3. Product Benchmarking 7.10.4. Recent Developments Access Press Release on Platinum Based Cancer Drugs Market: https://www.polarismarketresearch.com/press-releases/platinum-based-cancer-drugs-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com/ - 8 -

More Related